Iofina Regulatory News (IOF)

17 December 2013

Iofina plc.

("Iofina" or the "Group")

(LSE AIM: IOF)

Director Dealing

Iofina, specialists in the exploration and production of iodine and iodine specialty chemical derivatives, were informed today that Chris Fay, Non-Executive Chairman of the Group has today purchased 50,000 ordinary shares at an average price of 101p. Mr Fay now holds 1,300,000 ordinary shares in the Company, representing 1.02 per cent of the Company's issued share capital.

For further information, please contact:

George Lantz, CEO

Iofina plc

Tel: +44 (0) 20 3006 3135

www.iofina.com 

Ben Colegrave/Chris Sim/ James Rudd

Investec

Tel: +44(0)20 7597 5970

Media Contact:

Dominic Barretto/Anna Legge

Yellow Jersey PR Limited

Tel: +44(0) 7768 537 739

About Iofina

Iofina specializes in the exploration and production of iodine, iodine specialty chemical derivatives, produced water and natural gas. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America based on Iofina's WET® IOsorb™ technology. Iofina has iodine production operations in the United States, specifically in Texas, California, Montana, Oklahoma and Wyoming. The Group has complete vertical integration from the production of iodine in the field to the manufacture of the chemical end products derived from iodine to the consumer and the recycling of iodine using iodinated side-streams from waste chemical processes in Europe, North America and Asia. The Group utilizes its portfolio of patented and patent pending technology, proprietary methods and trademarks throughout all business lines.